
浏览全部资源
扫码关注微信
400042 重庆,第三军医大学大坪医院野战外科研究所创伤实验室,骨代谢与修复中心,创伤、烧伤与复合伤国家重点实验室
[陈林,E-mail: linchen70@163.com Chen Lin, E-mail: linchen70@163.com
收稿:2016-11-30,
修回:2017-02-13,
纸质出版:2017-05-30
移动端阅览
郭静远, 王权, 温轩, 等. 成纤维细胞生长因子抑制长链非编码RNA Malat1的表达及对软骨细胞增殖的影响[J]. 第三军医大学学报, 2017,39(10):946-953.
Jingyuan Guo, Quan Wang, Xuan Wen, et al. Role of fibroblast growth factor pathway in regulating expression of long non-coding RNA Malat1 and proliferation of chondrocytes
郭静远, 王权, 温轩, 等. 成纤维细胞生长因子抑制长链非编码RNA Malat1的表达及对软骨细胞增殖的影响[J]. 第三军医大学学报, 2017,39(10):946-953. DOI: 10.16016/j.1000-5404.201611251.
Jingyuan Guo, Quan Wang, Xuan Wen, et al. Role of fibroblast growth factor pathway in regulating expression of long non-coding RNA Malat1 and proliferation of chondrocytes
目的
2
探讨在软骨细胞模型中成纤维细胞生长因子通路对长链非编码RNA(long non-coding RNA,LncRNA)Malat1的调控作用。
方法
2
采用Ⅰ型成纤维细胞生长因子受体(fibroblast growth factor receptor 1,Fgfr1) 组织特异性敲除小鼠和Ⅲ型成纤维细胞生长因子受体(fibroblast growth factor receptor 3,Fgfr3) 敲除小鼠的原代软骨,以及利用软骨细胞系培养充当软骨细胞模型,成纤维细胞生长因子2(fibroblast growth factor 2,FGF2) 及下游细胞外调节蛋白激酶(extracellular regulated protein kinases,ERK)通路阻断剂U0126处理细胞,利用荧光定量PCR检测Malat1的表达变化。在ATDC5细胞模型中通过siRNA转染干扰Malat1或Fgfr1,质粒转染过表达Fgfr1,利用荧光定量PCR检测Malat1的表达,细胞计数检测细胞增殖变化。
结果
2
Malat1被干扰24、36、48、60 h后,ATDC5细胞增殖速度显著减慢(
P
<
0.05),FGF2处理ATDC5细胞24 h后Malat1表达显著下降(
P
<
0.05),且ERK通路抑制剂U0126处理细胞后FGF2对Malat1的抑制作用消失。Fgfr1条件性敲除或si-Fgfr1干扰后Malat1表达显著升高(
P
<
0.05),且FGF2对Malat1的抑制作用消失,Fgfr1在ATDC5细胞中过表达后Malat1表达与对照组相比显著降低(
P
<
0.05)。
结论
2
软骨细胞中FGF2可能通过Fgfr1激活下游ERK通路,抑制了Malat1的表达,从而影响软骨细胞增殖。
Objective
2
To investigate the role of fibroblast growth factor pathway in the regulation of long non-coding RNA(LncRNA) Malat1 in chondrocytes.
Methods
2
Primary chondrocytes isolated from mice with tissue-specific knockout of fibroblast growth factor receptor 1 (Fgfr1) and Fgfr3 and
in vitro
cultured chondrocyte lines were treated with fibroblast growth factor 2 (FGF2) and U0126
a blocker of the downstream extracellular regulated protein kinases (ERK)
and the expression level of Malat1 in the cells was detected with qPCR. ATDC5 cells with small interfering RNA (siRNA)-mediated silencing of Malat1 or Fgfr1 gene and cells with Fgfr1 overexpression were examined for the expression level of Malat1 using qPCR
and the cell proliferation was assessed by cell counting.
Results
2
The proliferation of ATDC5 cells was suppressed after siRNA-mediated silencing of Malat1. Treatment with FGF2 significantly down-regulated the expression level of Malat1 in ATDC5 cells
and this inhibitory effect was abolished by the application of the ERK pathway blocker U0126. Conditional knockout or interference of Fgfr1 resulted in significant up-regulation of Malat1 expression and abolished the inhibitory effect of FGF2 in ATDC5 cells
while overexpression of Fgfr1 in ATDC5 cells caused significant down-regulation of Malat1 expression.
Conclusion
2
In chondrocytes
FGF2 inhibits Malat1 expression by activating the ERK pathway through Fgfr1 suppressing the cell proliferation.
Long F, Ornitz D M. Development of the endochondral skeleton.[J]. Cold Spring Harbor Perspectives in Biology, 2013, 5(1): a008334. DOI: 10.1101/cshperspect.a008334.
Su N, Jin M, Chen L. Role of FGF/Fgfr signaling in skeletal development and homeostasis: learning from mouse models[J]. Bone Research, 2014, 2(1): 9-32. DOI: 10.1038/boneres.2014.3.
Horton W A, Hall J G, Hecht J T. Achondroplasia[J]. Lancet, 2007, 370(9582): 162-172. DOI: 10.1016/S0140-6736(07)61090-3.
Naski M C, Ornitz D M. FGF signaling in skeletal development[J]. Front Biosci, 1998, 3: d781-d794. DOI: 10.2741/a321.
Ornitz D M. FGF signaling in the developing endochondral skeleton[J]. Cytokine Growth Factor Rev, 2005, 16(2): 205-213. DOI: 10.1016/j.cytogfr.2005.02.003.
李晓刚, 苏楠, 唐玉彬, 等. FGF2对破骨细胞体外分化以及骨吸收功能的直接调控作用[J].第三军医大学学报, 2014, 36(7): 636-639. DOI: 10.16016/j.1000-5404.2014.07.003.
Li X G, Su N, Tang Y B, et al. Fibroblast growth factor 2 directly regulates osteoclast differentiation and bone resorption function[J]. J Third Mil Med Univ, 2014, 36(7): 636-639.DOI: 10.16016/j.1000-5404.2014.07.003.
谢杨丽. Fgfr3在骨骼发育、稳态维持中的作用与相关机制研究[D].第三军医大学, 2013.
Xie Y L.The role and mechanism of Fgfr3 in skeleton development and homostasis[D]. Third Military Medical University, 2013.
Karuppaiah K, Yu K, Lim J, et al. FGF signaling in the osteoprogenitor lineage non-autonomously regulates postnatal chondrocyte proliferation and skeletal growth[J]. Development, 2016, 143(10): 1811-1822. DOI: 10.1242/dev.131722.
Ornitz D M, Marie P J. FGF signaling pathways in endochondral and intramembranous bone development and human genetic disease[J]. Genes Dev, 2002, 16(12): 1446-1465. DOI: 10.1101/gad.990702.
Flynn R A, Chang H Y. Long noncoding RNAs in cell-fate programming and reprogramming[J]. Cell Stem Cell, 2014, 14(6): 752-761. DOI: 10.1016/j.stem.2014.05.014.
Wang K C, Chang H Y. Molecular mechanisms of long noncoding RNAs[J]. Mol Cell, 2011, 43(6): 904-914. DOI: 10.1016/j.molcel.2011.08.018.
Whitehead J, Pandey G K, Kanduri C. Regulation of the mammalian epigenome by long noncoding RNAs[J]. BiochimBiophys Acta, 2009, 1790(9): 936-947. DOI: 10.1016/j.bbagen.2008.10.007.
Ji P, Diederichs S, Wang W, et al. MALAT-1, a novel noncoding RNA, and thymosin beta4 predict metastasis and survival in early-stage non-small cell lung cancer[J]. Oncogene, 2003, 22(39): 8031-8041. DOI: 10.1038/sj.onc.1206928.
Gutschner T, Hammerle M, Diederichs S. MALAT1--a paradigm for long noncoding RNA function in cancer[J]. J Mol Med, 2013, 91(7): 791-801. DOI: 10.1007/s00109-013-1028-y.
Liu M, Sun W, Liu Y, et al. The role of lncRNA MALAT1 in bone metastasis in patients with non-small cell lung cancer[J]. Oncol Rep, 2016, 36(3): 1679-1685. DOI: 10.3892/or.2016.4909.
齐文川, 李骞, 吴传芳.低表达长非编码RNA MALAT1对人宫颈癌HeLa细胞体外生长和迁移的影响[J].四川大学学报(自然科学版), 2015, 52(4): 901-905.DOI: 103969/j.issn.0490-6756.2015.07.034.
Qi W C, Li Q, Wu C F. Lower expression lncRNA MALAT1 effect on the proliferation and migration of HeLa cells in vitro[J]. J Sichuan University(Nature Science Edition), 2015, 52(4): 901-905.DOI: 103969/j.issn.0490-6756. 2015.07.034.
宋铁峰, 袁颖, 王会琴, 等.长链非编码RNA MALAT1的研究进展[J].生物技术通报, 2016, 32(1): 20-28.DOI: 10.13560/j.cnki.biotech.bull.1985.2016.01.005.
Song T F, Yuan Y, Wang H Q, et al. Research Progress on a Long Non-coding RNA MALAT1[J]. BIOTECHNOLOGY BULLETIN, 2016, 32(1): 20-28.DOI: 10.13560/j.cnki.biotech.bull.1985.2016.01.005.
Fang D, Yang H, Lin J, et al. 17β-estradiol regulates cell proliferation, colony formation, migration invasion and promotes apoptosis by upregulating miR-9 and thus degrades MALAT-1 in osteosarcoma cell MG-63 in an estrogen receptor-independent manner[J]. Biochem Biophys Res Commun, 2015, 457(4): 500-506. DOI: 10.1016/j.bbrc. 2014.12.114.
Dong Y, Liang G, Yuan B, et al. MALAT1 promotes the proliferation and metastasis of osteosarcoma cells by activating the PI3K/Akt pathway[J]. Tumour Biol, 2015, 36(3): 1477-1486. DOI: 10.1007/s13277-014-2631-4.
Jin M, Yu Y, Qi H, et al. A novel Fgfr3-binding peptide inhibits Fgfr3 signaling and reverses the lethal phenotype of mice mimicking human thanatophoric dysplasia[J]. Hum Mol Genet, 2012, 21(26): 5443-5455. DOI: 10.1093/hmg/dds390.
Che W, Dong Y, Quan H B. RANKL inhibits cell proliferation by regulating MALAT1 expression in a human osteoblastic cell line hFOB 1.19[J]. Cell Mol Biol (Noisy-le-grand), 2015, 61(1): 7-14.
Zhang B, Arun G, Mao Y S, et al. The lncRNA Malat1 is dispensable for mouse development but its transcription plays a cis-regulatory role in the adult[J]. Cell Rep, 2012, 2(1): 111-123. DOI: 10.1016/j.celrep.2012.06.003.
Chen L, Feng P, Zhu X, et al. Long non-coding RNA Malat1 promotes neurite outgrowth through activation of ERK/MAPK signalling pathway in N2a cells[J]. J Cell Mol Med, 2016, 20(11): 2102-2110.DOI: 10.1111/jcmm.12904.
0
浏览量
0
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621